Authors: NORRBY SR FAULKNER KL NEWELL PA

Citation: Sr. Norrby et al., DIFFERENTIATING MEROPENEM AND IMIPENEM CILASTATIN/, Infectious diseases in clinical practice, 6(5), 1997, pp. 291-303

Authors: BRADLEY JS FAULKNER KL

Citation: Js. Bradley et Kl. Faulkner, EFFICACY, SAFETY AND TOLERABILITY OF MEROPENEM AS EMPIRIC ANTIBIOTIC-THERAPY IN HOSPITALIZED PEDIATRIC-PATIENTS, The Pediatric infectious disease journal, 15(8), 1996, pp. 749-757

Authors: COLARDYN F FAULKNER KL

Citation: F. Colardyn et Kl. Faulkner, INTRAVENOUS MEROPENEM VERSUS IMIPENEM CILASTATIN IN THE TREATMENT OF SERIOUS BACTERIAL-INFECTIONS IN HOSPITALIZED-PATIENTS/, Journal of antimicrobial chemotherapy, 38(3), 1996, pp. 523-537

Authors: HUTCHISON M FAULKNER KL TURNER PJ HAWORTH SJ SHEIKH W NADLER H PITKIN DH

Citation: M. Hutchison et al., A COMPILATION OF MEROPENEM TISSUE DISTRIBUTION DATA, Journal of antimicrobial chemotherapy, 36, 1995, pp. 43-56

Authors: NORRBY SR NEWELL PA FAULKNER KL LESKY W

Citation: Sr. Norrby et al., SAFETY PROFILE OF MEROPENEM - INTERNATIONAL CLINICAL-EXPERIENCE BASEDON THE FIRST 3125 PATIENTS TREATED WITH MEROPENEM, Journal of antimicrobial chemotherapy, 36, 1995, pp. 207-223